{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T04:30:00Z","timestamp":1726806600068},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To investigate the association between white-coat hypertension (WCH) and acute retinal vein occlusion (RVO).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this retrospective case-control study, patients aged 40 years or older diagnosed with acute-phase RVO were included. Patients with other pathologies served as non-RVO controls. Blood pressure (BP) was measured in the office during their initial visit, and information about home BP and hypertension (HTN) medication was obtained through interviews. After 1:2 age and sex-matching between the RVO and non-RVO groups, the proportions of HTN cases were compared. A similar comparison was made in subgroups with or without HTN medication.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fifty-one patients with RVO and 102 with non-RVO were included in the analysis. For the entire cohort, the RVO group exhibited a significantly greater proportion of WCH and sustained HTN compared to the non-RVO group. In the subgroup without HTN treatment, the proportion of WCH or sustained HTN was still significantly higher in the RVO group. However, in the subgroup receiving HTN treatment, the proportion of WCH or sustained HTN was higher in the RVO group than in the non-RVO group, though not statistically significant.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case-control study suggests that WCH may be associated with RVO, particularly in patients without HTN treatment. Given that interventions for WCH have not been standardized, a more detailed and prospective study is warranted to elucidate the risk of WCH for RVO and other retinal vascular diseases.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-024-00584-y","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T20:05:21Z","timestamp":1726776321000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["White coat hypertension in acute retinal vein occlusion"],"prefix":"10.1186","volume":"10","author":[{"given":"Shuichiro","family":"Aoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohdai","family":"Kitamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Obata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"issue":"2","key":"584_CR1","doi-asserted-by":"publisher","first-page":"P288","DOI":"10.1016\/j.ophtha.2019.09.029","volume":"127","author":"CJ Flaxel","year":"2020","unstructured":"Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA. Ying G-s: retinal vein Occlusions Preferred Practice Pattern\u00ae. Ophthalmology. 2020;127(2):P288\u2013320.","journal-title":"Ophthalmology"},{"issue":"12","key":"584_CR2","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1097\/IAE.0000000000001071","volume":"36","author":"VN Rao","year":"2016","unstructured":"Rao VN, Ulrich JN, Viera AJ, Parlin A, Fekrat S, Chavala SH. AMBULATORY BLOOD PRESSURE PATTERNS IN PATIENTS WITH RETINAL VEIN OCCLUSION. Retina (Philadelphia Pa). 2016;36(12):2304.","journal-title":"Retina (Philadelphia Pa)"},{"issue":"1","key":"584_CR3","doi-asserted-by":"publisher","first-page":"10505","DOI":"10.1038\/s41598-021-89915-9","volume":"11","author":"GM Noh","year":"2021","unstructured":"Noh GM, Lee H, Kwak HD, Kim HW, Lee SJ. Non-dipping pattern of nocturnal blood pressure as a risk factor for macular ischemia in branch retinal vein occlusion. Sci Rep. 2021;11(1):10505.","journal-title":"Sci Rep"},{"issue":"1","key":"584_CR4","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1038\/s41598-020-61386-4","volume":"10","author":"H-J Kim","year":"2020","unstructured":"Kim H-J, Shin YU, Lee Y, Kang MH, Seong M, Cho H, Heo R, Park J-k, Lim Y-H, Shin J-H. Increasing incidence of macular edema in excessive morning blood pressure surge in patients with retinal vein occlusion. Sci Rep. 2020;10(1):4420.","journal-title":"Sci Rep"},{"issue":"6","key":"584_CR5","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","volume":"75","author":"T Unger","year":"2020","unstructured":"Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, Ramirez A, Schlaich M, Stergiou GS, Tomaszewski M, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334\u201357.","journal-title":"Hypertension"},{"issue":"9","key":"584_CR6","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, Horio T, Hoshide S, Ikeda S, Ishimitsu T, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235\u2013481.","journal-title":"Hypertens Res"},{"issue":"22","key":"584_CR7","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1056\/NEJMra060433","volume":"354","author":"TG Pickering","year":"2006","unstructured":"Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354(22):2368\u201374.","journal-title":"N Engl J Med"},{"key":"584_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/IBPC.S128947","volume":"11","author":"M Palla","year":"2018","unstructured":"Palla M, Saber H, Konda S, Briasoulis A. Masked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis. Integr Blood Press Control. 2018;11:11\u201324.","journal-title":"Integr Blood Press Control"},{"issue":"12","key":"584_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.7326\/M19-0223","volume":"170","author":"JB Cohen","year":"2019","unstructured":"Cohen JB, Lotito MJ, Trivedi UK, Denker MG, Cohen DL, Townsend RR. Cardiovascular events and mortality in White Coat Hypertension. Ann Intern Med. 2019;170(12):853\u201362.","journal-title":"Ann Intern Med"},{"issue":"6","key":"584_CR10","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1161\/HYPERTENSIONAHA.113.01275","volume":"62","author":"SS Franklin","year":"2013","unstructured":"Franklin SS, Thijs L, Hansen TW, O\u2019Brien E, Staessen JA. White-Coat hypertension. Hypertension. 2013;62(6):982\u20137.","journal-title":"Hypertension"},{"key":"584_CR11","doi-asserted-by":"publisher","first-page":"175394472093163","DOI":"10.1177\/1753944720931637","volume":"14","author":"G Nuredini","year":"2020","unstructured":"Nuredini G, Saunders A, Rajkumar C, Okorie M. Current status of white coat hypertension: where are we? Ther Adv Cardiovasc Dis. 2020;14:1753944720931637.","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"10","key":"584_CR12","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41371-018-0140-4","volume":"33","author":"F Spannella","year":"2019","unstructured":"Spannella F, Filipponi A, Giulietti F, Balietti P, Bernardi B, Rosettani G, Sarzani R. Prognostic role of masked and white-coat hypertension: 10-Year mortality in treated elderly hypertensives. J Hum Hypertens. 2019;33(10):741\u20137.","journal-title":"J Hum Hypertens"},{"issue":"4","key":"584_CR13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/HJH.0b013e328350a69b","volume":"30","author":"M-RA H\u00e4nninen","year":"2012","unstructured":"H\u00e4nninen M-RA, Niiranen TJ, Puukka PJ, Johansson J, Jula AM. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study. J Hypertens. 2012;30(4):705.","journal-title":"J Hypertens"},{"issue":"1","key":"584_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.medcli.2012.04.031","volume":"140","author":"VN Figueiredo","year":"2013","unstructured":"Figueiredo VN, Martins LC, Boer-Martins L, Cabral de Faria AP, de Haro Moraes C, Cardoso Santos R, Nogueira AR, Moreno H. The white coat effect is not associated with additional increase of target organ damage in true resistant hypertension. Med Clin. 2013;140(1):1\u20135.","journal-title":"Med Clin"},{"issue":"5","key":"584_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1161\/HYPERTENSIONAHA.121.18792","volume":"79","author":"G Mancia","year":"2022","unstructured":"Mancia G, Facchetti R, Vanoli J, Dell\u2019Oro R, Seravalle G, Grassi G. White-Coat Hypertension without Organ damage: impact on long-term mortality, New Hypertension, and New Organ damage. Hypertension. 2022;79(5):1057\u201366.","journal-title":"Hypertension"},{"issue":"11","key":"584_CR16","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/jch.14573","volume":"24","author":"R Cao","year":"2022","unstructured":"Cao R, Yue J, Gao T, Sun G, Yang X. Relations between white coat effect of blood pressure and arterial stiffness. J Clin Hypertens. 2022;24(11):1427\u201335.","journal-title":"J Clin Hypertens"},{"issue":"5","key":"584_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/archopht.1996.01100130537006","volume":"114","author":"Risk Factors for Central Retinal Vein Occlusion","year":"1996","unstructured":"Risk Factors for Central Retinal Vein Occlusion. Arch Ophthalmol. 1996;114(5):545\u201354.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"584_CR18","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/bjo.2008.140640","volume":"92","author":"LL Lim","year":"2008","unstructured":"Lim LL, Cheung N, Wang JJ, Islam FMA, Mitchell P, Saw SM, Aung T, Wong TY. Prevalence and risk factors of retinal vein occlusion in an Asian population. Br J Ophthalmol. 2008;92(10):1316\u20139.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"584_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0002-9394(00)00709-1","volume":"131","author":"SS Hayreh","year":"2001","unstructured":"Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001;131(1):61\u201377.","journal-title":"Am J Ophthalmol"},{"issue":"9559","key":"584_CR20","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0140-6736(07)60198-6","volume":"369","author":"T Wong","year":"2007","unstructured":"Wong T, Mitchell P. The eye in hypertension. Lancet. 2007;369(9559):425\u201335.","journal-title":"Lancet"},{"issue":"13","key":"584_CR21","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1001\/archinte.165.13.1541","volume":"165","author":"T Ugajin","year":"2005","unstructured":"Ugajin T, Hozawa A, Ohkubo T, Asayama K, Kikuya M, Obara T, Metoki H, Hoshi H, Hashimoto J, Totsune K, et al. White-Coat hypertension as a risk factor for the development of Home Hypertension: the Ohasama Study. Arch Intern Med. 2005;165(13):1541\u20136.","journal-title":"Arch Intern Med"},{"issue":"4","key":"584_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/HJH.0000000000000832","volume":"34","author":"A Briasoulis","year":"2016","unstructured":"Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D. White-coat hypertension and cardiovascular events: a meta-analysis. J Hypertens. 2016;34(4):593\u20139.","journal-title":"J Hypertens"},{"issue":"1","key":"584_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/HJH.0000000000000416","volume":"33","author":"C Cuspidi","year":"2015","unstructured":"Cuspidi C, Rescaldani M, Tadic M, Sala C, Grassi G, Mancia G. White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis. J Hypertens. 2015;33(1):24.","journal-title":"J Hypertens"},{"issue":"4","key":"584_CR24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1097\/HJH.0b013e32801d1f62","volume":"25","author":"G de Simone","year":"2007","unstructured":"de Simone G, Schillaci G, Chinali M, Angeli F, Reboldi GP, Verdecchia P. Estimate of white-coat effect and arterial stiffness. J Hypertens. 2007;25(4):827.","journal-title":"J Hypertens"},{"issue":"6","key":"584_CR25","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0895-7061(03)00843-4","volume":"16","author":"G Mul\u00e8","year":"2003","unstructured":"Mul\u00e8 G, Nardi E, Cottone S, Andronico G, Federico MR, Piazza G, Volpe V, Ferrara D, Cerasola G. Relationships between ambulatory white coat effect and left ventricular mass in arterial hypertension*. Am J Hypertens. 2003;16(6):498\u2013501.","journal-title":"Am J Hypertens"},{"issue":"11","key":"584_CR26","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/jch.12888","volume":"18","author":"E Manios","year":"2016","unstructured":"Manios E, Michas F, Stamatelopoulos K, Koroboki E, Lykka A, Vettou C, Vemmos K, Zakopoulos N. White-Coat isolated systolic hypertension is a risk factor for carotid atherosclerosis. J Clin Hypertens. 2016;18(11):1095\u2013102.","journal-title":"J Clin Hypertens"},{"issue":"9","key":"584_CR27","first-page":"429","volume":"1","author":"G Rauh","year":"1996","unstructured":"Rauh G, Fischereder M, Nasemann J, M\u00fcller M, Gr\u00fcterich M, Spannagl M, Spengel FA. Evaluation of atherosclerosis in patients with central retinal vein occlusion by carotid artery duplex scanning and echocardiography: a prospective case-control study. Eur J Med Res. 1996;1(9):429\u201332.","journal-title":"Eur J Med Res"},{"issue":"4","key":"584_CR28","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1177\/1120672120937669","volume":"31","author":"LJ Fang","year":"2021","unstructured":"Fang LJ, Dong L, Li YF, Wei WB. Retinal vein occlusion and chronic kidney disease: a meta-analysis. Eur J Ophthalmol. 2021;31(4):1945\u201352.","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"584_CR29","first-page":"126","volume":"7","author":"E Bozkurt","year":"2022","unstructured":"Bozkurt E, Cetin T, Rencuzogullari I. Evaluation of systemic endothelial dysfunction in retinal vein occlusions. Beyoglu Eye J. 2022;7(2):126\u201333.","journal-title":"Beyoglu Eye J"},{"issue":"9","key":"584_CR30","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1097\/HJH.0b013e328363e964","volume":"31","author":"E O\u2019Brien","year":"2013","unstructured":"O\u2019Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31(9):1731\u201368.","journal-title":"J Hypertens"},{"issue":"1","key":"584_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/hr.2014.149","volume":"38","author":"M Gorostidi","year":"2015","unstructured":"Gorostidi M, Vinyoles E, Banegas JR, de la Sierra A. Prevalence of white-coat and masked hypertension in national and international registries. Hypertens Research: Official J Japanese Soc Hypertens. 2015;38(1):1\u20137.","journal-title":"Hypertens Research: Official J Japanese Soc Hypertens"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-024-00584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-024-00584-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-024-00584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T20:05:23Z","timestamp":1726776323000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-024-00584-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1186\/s40942-024-00584-y","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Institutional Review Board (IRB) of the University of Tokyo (reference number: 2217) on 22nd February 2023 and conducted in accordance with the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"In alignment with the Japanese Guidelines for Epidemiologic Study issued by the Japanese Government, the ethics committee waived the requirement for patient\u2019s informed consent pertaining to the use of their medical record data. As a form of transparency, the study protocol was displayed at the outpatient clinic to keep patients informed about the ongoing research. Patients who declined the use of their medical records for research purposes were subsequently excluded.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}